News

National Institute of Health (NIH) issued a notice seeking comment on a proposal to amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines

We understand that one of our top areas for improvement continues to be the time it takes for investigators to initiate clinical trials, and as such, this is an active area of focus for us, along with more general improvements and streamlining of our clinical research operations. This is an update to report on our progress in these efforts.

UPDATE: This position has been filled.

Interested in learning about cutting-edge research conducted by world-class investigators?
Want to explore ethical issues in human subjects’ protections?
Come work with the IRB!

Interested in learning about cutting-edge research conducted by world-class investigators?
Want to explore ethical issues in human subjects’ protections?
Come work with the IRB!

UPDATE February 7: This issue has been resolved, and UCSF’s access to the CITI website has been restored.
The Office of Human Research Protections announced that proposed revisions to the “Federal Policy for the Protection of Human Subjects” (also known as the Common Rule) have been delayed by 6 months. The majority of provisions in the Revised Common Rule are now set to take effect on July 19, 2018.

The IRB has created a new “Protocol Enrollment Exception Request” submission form and it is now available in iRIS.

When do I use the Protocol Enrollment Exception Request form?

The office of the Human Research Protection Program (HRPP) will be closed December 25th – January 1st and will re-open on January 2nd. Please note there will be no AOTD service during this time.

If you have questions about Emergency Use of a test article, contact Laurie Herraiz, HRPP Director, at 415-514-9246.

The message below is senton behalf of Brian Smith, Associate Vice Chancellor, Interim Chief Ethics and Compliance Officer

Pages